Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 1
2010 2
2011 2
2012 4
2013 1
2014 1
2015 1
2016 2
2017 11
2018 18
2019 26
2020 21
2021 36
2022 29
2023 13
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
Response.
Hozumi H, Kono M, Hasegawa H, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Yokomura K, Nakamura H, Suda T. Hozumi H, et al. Among authors: furuhashi k. Chest. 2021 Dec;160(6):e683-e685. doi: 10.1016/j.chest.2021.07.044. Chest. 2021. PMID: 34872693 No abstract available.
Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosis.
Naoi H, Suzuki Y, Mori K, Aono Y, Kono M, Hasegawa H, Yokomura K, Inoue Y, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Nakamura H, Suda T. Naoi H, et al. Among authors: furuhashi k. Thorax. 2022 Jul;77(7):727-730. doi: 10.1136/thoraxjnl-2021-218281. Epub 2022 Mar 30. Thorax. 2022. PMID: 35354649
A predictive model for acute exacerbation of idiopathic interstitial pneumonias.
Karayama M, Aoshima Y, Suzuki T, Mori K, Yoshizawa N, Ichikawa S, Kato S, Yokomura K, Kono M, Hashimoto D, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Goshima S, Inui N, Suda T. Karayama M, et al. Among authors: furuhashi k. Eur Respir J. 2023 May 5;61(5):2201634. doi: 10.1183/13993003.01634-2022. Print 2023 May. Eur Respir J. 2023. PMID: 36822633 Free PMC article.
Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial.
Fujisawa T, Hozumi H, Kamiya Y, Kaida Y, Akamatsu T, Kusagaya H, Satake Y, Mori K, Mikamo M, Matsuda H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T. Fujisawa T, et al. Among authors: furuhashi k. Respirology. 2021 Apr;26(4):370-377. doi: 10.1111/resp.13978. Epub 2020 Nov 11. Respirology. 2021. PMID: 33179395 Free article. Clinical Trial.
Six-week oral prednisolone therapy for immune-related pneumonitis: a single-arm phase II study.
Karayama M, Inui N, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Asada K, Uto T, Fujii M, Matsui T, Matsuura S, Hashimoto D, Toyoshima M, Ikeda M, Matsuda H, Inami N, Kaida Y, Funayama S, Ichikawa S, Goshima S, Suda T. Karayama M, et al. Among authors: furuhashi k. J Immunother Cancer. 2023 Jul;11(7):e007056. doi: 10.1136/jitc-2023-007056. J Immunother Cancer. 2023. PMID: 37500182 Free PMC article. Clinical Trial.
Transient leukocytopenia following combination therapy for COVID-19.
Tsuchiya K, Fujisawa T, Mochizuka Y, Takuma S, Oishi K, Endo Y, Tanaka Y, Fukada A, Watanabe H, Katsumata M, Aoshima Y, Inoue Y, Suzuki Y, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T. Tsuchiya K, et al. Among authors: furuhashi k. Respir Investig. 2022 Jan;60(1):158-161. doi: 10.1016/j.resinv.2021.09.007. Epub 2021 Oct 9. Respir Investig. 2022. PMID: 34649811 Free PMC article.
Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis.
Mochizuka Y, Suzuki Y, Kono M, Hasegawa H, Hashimoto D, Yokomura K, Inoue Y, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura H, Suda T. Mochizuka Y, et al. Among authors: furuhashi k. Respirology. 2023 Aug;28(8):775-783. doi: 10.1111/resp.14523. Epub 2023 May 23. Respirology. 2023. PMID: 37221050
Prognostic significance of radiological pleuroparenchymal fibroelastosis in Mycobacterium avium complex lung disease: a multicentre retrospective cohort study.
Aono Y, Hozumi H, Kono M, Hashimoto D, Nakamura H, Yokomura K, Imokawa S, Shirai M, Akahori D, Inoue Y, Mori K, Karayama M, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T. Aono Y, et al. Among authors: furuhashi k. Thorax. 2023 Aug;78(8):825-834. doi: 10.1136/thorax-2022-219116. Epub 2022 Nov 11. Thorax. 2023. PMID: 36368892
Prognostic Role of Interferon-λ3 in Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis-Associated Interstitial Lung Disease.
Fukada A, Fujisawa T, Hozumi H, Koda K, Akamatsu T, Oyama Y, Satake Y, Niwa M, Kaida Y, Matsuda H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Hashimoto D, Yoshida A, Gono T, Kuwana M, Yamano Y, Kondoh Y, Yamashita K, Maekawa M, Mori K, Inoue Y, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Inui N, Suda T. Fukada A, et al. Among authors: furuhashi k. Arthritis Rheumatol. 2024 May;76(5):796-805. doi: 10.1002/art.42785. Epub 2024 Feb 6. Arthritis Rheumatol. 2024. PMID: 38146102
Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study.
Miyashita K, Hozumi H, Furuhashi K, Nakatani E, Inoue Y, Yasui H, Karayama M, Suzuki Y, Fujisawa T, Enomoto N, Inui N, Ojima T, Suda T. Miyashita K, et al. Among authors: furuhashi k. Emerg Microbes Infect. 2023 Dec;12(1):2155250. doi: 10.1080/22221751.2022.2155250. Emerg Microbes Infect. 2023. PMID: 36469641 Free PMC article.
160 results